6 min. Read

PWNHealth pricing and estimated revenues. Pharma spin-outs.

Issue 094

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

E&O Fridays.

OK, here's what's

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases

Help me get ahead. $200/year

Newsletters

UnitedHealth’s employee benefits. Omada signals IPO. Detailed Spring Health pricing.

11.21.23

9 min. Read

CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.

11.16.23

8 min. Read

Lyra Health pricing. Spring Health signals IPO.

11.09.23

6 min. Read

metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger

11.06.23

6 min. Read

PDT Pipeline changes. Kinsa shuts down. Trials

10.27.23

5 min. Read

CPT decisions. Trials: Big Health, Mahana and more

10.20.23

6 min. Read

Teladoc quietly bought MSK startup. Omada hits 1M milestone.

10.13.23

5 min. Read

Akili CEO steps down. Aetna rolls back some virtual care coverage

10.06.23

5 min. Read

Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.

9.29.23

6 min. Read

CMS: PDTs have potential. Trials: Big, Koko, GAIA

9.22.23

6 min. Read

PWNHealth pricing and estimated revenues. Pharma spin-outs.

E&O Fridays.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.